AIRS
AirSculpt Technologies, Inc.
AIRS trails on the overall score without a compensating advantage in the available component scores.
NVO
Novo Nordisk A/S
NVO has the edge over AIRS overall on the model score.
AIRS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Under pressure | |
| Weak |
AIRS's revenue is currently stable, but its profitability, cash flow and balance sheet are under pressure.
NVO Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Healthy |
NVO's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
AIRS PE Valuation
AIRS has no meaningful PE right now: it lost money over the past year.
NVO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 10x | $40.65 | — |
| Cheap | 14x | $53.56 | +32% |
| Fair | 27x | $103 | +154% |
| Expensive | 39x | $152 | +273% |
Historical ranges are pointers, not guarantees.
NVO's PE is 10x, but its earnings don't support one, so it isn't a reliable read right now.
AIRS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Stable | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect AIRS's losses to grow, with revenue holding steady.
NVO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Stable | |
| Growth | |
| Weakening | |
| Limited | |
| Low |
NVO has the edge over AIRS on the outlook, with more favorable earnings and revenue expectations.
AIRS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.13 | +$0.16 |
| Q2 2026 | -$0.18 | +$0.06 |
| Q1 2026 | -$0.17 | +$0.12 |
| Q4 2025 | -$0.19 | -$0.05 |
| Q3 2025 | -$0.29 | -$0.15 |
| Q2 2025 | -$0.24 | -$0.17 |
| Q1 2025 | -$0.29 | -1550% |
| Q4 2024 | -$0.14 | -$0.06 |
AIRS is still losing money, but far less than before: $0.13 per share over the past year, against $0.29 at its worst in early 2025.
NVO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $3.89 | +4.9% |
| Q1 2026 | $4.07 | +17% |
| Q4 2025 | $3.42 | +1.8% |
| Q3 2025 | $3.47 | +10% |
| Q2 2025 | $3.71 | +24% |
| Q1 2025 | $3.49 | +18% |
| Q4 2024 | $3.36 | +21% |
| Q3 2024 | $3.15 | +27% |
NVO has the edge over AIRS on earnings quality, reporting a profit while its opponent remains loss making.
AIRS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $31.9M | -8.7% |
| Q2 2026 | $42.9M | -2.5% |
| Q1 2026 | $39.4M | 0% |
| Q4 2025 | $33.4M | -15% |
| Q3 2025 | $35M | -18% |
| Q2 2025 | $44M | -14% |
| Q1 2025 | $39.4M | -17% |
| Q4 2024 | $39.2M | -18% |
AIRS's revenue has slid since its 2023 peak: $32M last quarter, down 8.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -13% | +15 points |
| Q2 2026 | -0.1% | -1.9 points |
| Q1 2026 | -4.6% | -0.5 points |
| Q4 2025 | -3% | +7.5 points |
| Q3 2025 | -28% | -19 points |
| Q2 2025 | 1.8% | +12 points |
| Q1 2025 | -4% | -27 points |
| Q4 2024 | -11% | -14 points |
AIRS's operating margin was −13% last quarter, up 15 points from the same quarter a year ago, near the bottom of its range since 2020.
NVO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $11.7B | +2.1% |
| Q1 2026 | $14.4B | +24% |
| Q4 2025 | $11.8B | -7.6% |
| Q3 2025 | $11.1B | +5.1% |
| Q2 2025 | $11.4B | +13% |
| Q1 2025 | $11.6B | +19% |
| Q4 2024 | $12.7B | +30% |
| Q3 2024 | $10.6B | +21% |
NVO has the edge over AIRS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 34% | -9 points |
| Q1 2026 | 62% | +12 points |
| Q4 2025 | 40% | -2.8 points |
| Q3 2025 | 32% | -16 points |
| Q2 2025 | 44% | +5.4 points |
| Q1 2025 | 50% | +1 points |
| Q4 2024 | 43% | +2.2 points |
| Q3 2024 | 47% | +1.6 points |
NVO has the edge over AIRS on profitability, with a higher operating margin.
AIRS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$3.7M | -$3.3M |
| Q2 2026 | -$1.5M | -131% |
| Q1 2026 | $5.2M | +$6.3M |
| Q4 2025 | -$2.6M | -$1.8M |
| Q3 2025 | -$405K | +$2.7M |
| Q2 2025 | $4.7M | +$5.3M |
| Q1 2025 | -$1M | -157% |
| Q4 2024 | -$815K | -127% |
AIRS has burned cash in six of the last eight quarters: −$3M over the past year, against $2M the year before.
NVO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $6.3B | +73% |
| Q1 2026 | $1.8B | +20% |
| Q4 2025 | -$5.4B | -$4.7B |
| Q3 2025 | $4.6B | -2.1% |
| Q2 2025 | $3.6B | -34% |
| Q1 2025 | $1.5B | +89% |
| Q4 2024 | -$632.6M | +$390.5M |
| Q3 2024 | $4.7B | +3.3% |
NVO has the edge over AIRS on cash generation, producing positive trailing cash flow while its opponent burns cash.
AIRS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2.5% | +1.8M shares |
| 1 year | +16% | +10.1M shares |
| 3 years | +28% | +15.8M shares |
| 5 years | +31% | +17.2M shares |
| Available history | +30% | +16.9M shares |
AIRS has 73M diluted shares, up 16% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2021 | — |
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
NVO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -12.9M shares |
| 1 year | -0.2% | -11M shares |
| 3 years | -1.5% | -66.8M shares |
| 5 years | -3.8% | -177M shares |
| Available history | -6.5% | -311M shares |
NVO has the edge over AIRS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $520M |
| Q1 2026 | $356.7M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $206.3M |
| Q4 2024 | $1.1B |
| Q3 2024 | $357.4M |
NVO spent $877M buying back its own shares over the past year, down 48% from the year before.
AIRS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 4.3x | High |
| Q1 2026 | 35.7x | High |
| Q4 2025 | 39.0x | High |
| Q2 2025 | 12.3x | High |
| Q4 2024 | 6.1x | High |
| Q3 2024 | 4.2x | High |
| Q2 2024 | 3.1x | Elevated |
| Q1 2024 | 2.0x | Moderate |
AIRS's net debt is about 4.3 years of its operating earnings (EBITDA), down from 6.1 years a year ago.
NVO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.7x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.4x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.6x | Very low |
| Q3 2024 | -0.0x | Very low |
NVO has the edge over AIRS on leverage, with a lower net debt burden relative to earnings.
AIRS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.5 | Neutral |
| Stochastic | 7.2 | Oversold |
AIRS's weekly RSI is 32 (neutral) and its Stochastic is 7 (oversold).
NVO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.0 | Neutral |
| Stochastic | 27.0 | Neutral |
NVO's weekly RSI is 43 (neutral) and its Stochastic is 27 (neutral).
AIRS PE vs Healthcare Sector
| Metric | AIRS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
AIRS has no meaningful PE right now: it lost money over the past year.
NVO PE vs Healthcare Sector
| Metric | NVO | Sector median | Relative |
|---|---|---|---|
| PE | 10x | 26x | 60% below |
| PE % | 6 | 29 | 23 pts below |
NVO is trading at 10x earnings, a 60% discount to the Healthcare sector's median of 26x, though its earnings don't support one.
AIRS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.35 | 47% below |
| 20 week MA | $2.74 | 74% below |
| 50 week MA | $2.95 | 76% below |
| 100 week MA | $4.09 | 82% below |
| 200 week MA | $5.09 | 86% below |
AIRS is in a downtrend: it's below all five of its weekly moving averages, and 86% below its 200-week average.
NVO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $39.2 | 3.7% above |
| 20 week MA | $43.9 | 7.4% below |
| 50 week MA | $45.3 | 10% below |
| 100 week MA | $56.3 | 28% below |
| 200 week MA | $80.7 | 50% below |
NVO has the edge over AIRS on trend strength, trading above more of its moving averages.
AIRS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $15.9 | $14.5 | -8.7% |
| 2022 | $14.5 | $3.32 | -77% |
| 2023 | $3.32 | $7.49 | +126% |
| 2024 | $7.49 | $5.58 | -26% |
| 2025 | $5.58 | $2.03 | -64% |
| 2026 YTD | $2.03 | $0.72 | -65% |
AIRS's yearly returns have swung widely, from +126% in 2023 to −77% in 2022. It's down 65% so far in 2026.
NVO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $29.1 | $34.7 | +19% |
| 2021 | $34.7 | $54.2 | +56% |
| 2022 | $54.2 | $67.0 | +24% |
| 2023 | $67.0 | $103.5 | +54% |
| 2024 | $103.5 | $87.4 | -16% |
| 2025 | $87.4 | $52.4 | -40% |
| 2026 YTD | $52.4 | $40.7 | -22% |
NVO has the edge over AIRS on returns for 2026, with the stronger performance.